March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
Restoration of Meibomian Gland Function after Treatment for Meibomian Gland Dysfunction
Author Affiliations & Notes
  • Samuel Kim
    TearScience, Morrisville, North Carolina
  • Caroline A. Blackie
    TearScience, Morrisville, North Carolina
    Korb Associates, Boston, Massachusetts
  • Donald R. Korb
    TearScience, Morrisville, North Carolina
    Korb Associates, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Samuel Kim, TearScience (I, E); Caroline A. Blackie, TearScience (I, E); Donald R. Korb, TearScience (F, I, P)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 601. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Samuel Kim, Caroline A. Blackie, Donald R. Korb; Restoration of Meibomian Gland Function after Treatment for Meibomian Gland Dysfunction. Invest. Ophthalmol. Vis. Sci. 2012;53(14):601.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : To determine, retrospectively, whether previously non-functional meibomian glands could become functional rejuvenated after treatment.

Methods: : Patients diagnosed with meibomian gland dysfunction (MGD) and dry eye symptoms (n = 8) were treated with the LipiFlow Thermal Pulsation System in one 12-minute in-office treatment. They were followed at approximately 1 month and 12 months post treatment. At each visit, the functionality of the central five meibomian glands on the right and left lower eyelids was assessed using standardized diagnostic MG expression. For this specific region of the eyelid, the total number of MGs yielding liquid secretion (MGYLS, indicating MG function) was counted and recorded. The volume of liquid secretion for the central five glands was also recorded using the descriptors zero, minimal, moderate or copious. These descriptors were defined as follows: copious - the base diameter of the liquid secretion was 1 mm or more; moderate - the base diameter of the liquid secretion was approximately 0.5 mm; minimal - the base diameter of the liquid secretion was less than or equal to 0.3 mm. An index of volume was calculated by multiplying the number of MGYLS by 1 for minimal, 2 for moderate and 3 for copious and totaling these numbers for all five central MGs.

Results: : The mean age of the patients was 48.9 +/- 16.4 years (3 males; 5 females). There were no statistically significant differences between right and left eyes; data for right eyes only are presented. The mean number of MGYLS for the central 5 MGs at baseline = 1.1 +/- 0.8; 1 month = 3.5 +/- 1.2; 12 months = 3.1 +/- 0.6. The mean total volume index for the central 5 MGs at baseline = 1.6 +/- 1.5; 1 month = 6.5 +/- 2.9; 12 months = 5.5 +/- 2.3. The increase in MGYLS from baseline to 1 month was significant (p<0.0001); The change from 1 month to 12 months was not statistically significant. The increase in the volume index from baseline to 1 month was significant (p<0.0001); The change from 1 month to 12 months was not statistically significant (Repeated measures ANOVA with Bonferroni post hoc testing.)

Conclusions: : The increase in the number of functional MGs and the increase in the total volume of secretion of the central five lower lid MGs, maintained over a 12 month period, is evidence of restoration of MG function following treatment.

Keywords: cornea: tears/tear film/dry eye • eyelid 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×